Evidence map›Paper›PMID 39128227›Full record

ArticleRedox biology2024

Role of the telomeric factor TRF2 in post-hypoxic brain damages.

Shuaiyun Gao, Sheng Huang, Yiwen Xu, Bo Wang, Peng Cheng, Yiming Lu, Eric Gilson, Jing Ye

Abstract read
In one paragraph

Article in Redox biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuaiyun GaoDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China.
Sheng HuangDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China.
Yiwen XuDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China.
Bo WangDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China.
Peng ChengDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China.
Yiming LuDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China; Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: luyiming@rjh.com.cn.
Eric GilsonPôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; University Côte d'Azur, Inserm, CNRS, IRCAN, Nice, France; Department of Medical Genetics, IHU RespirERA, CHU, Nice, France. Electronic address: Eric.Gilson@unice.fr.
Jing YeDepartment of Geriatrics, Medical Center on Aging of Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Pôle Sino-Français de Recherches en Sciences du Vivant et Génomique, International Research Project Cancer, Aging and Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine/CNRS/INSERM/University Côte d'Azur, Shanghai, China; The State Key Laboratory of Medical Genomics, Shanghai, 200025, China; Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: yj11254@rjh.com.cn.

Funding

National Natural Science Foundation of China 82225018 , 92149302, 81971312 , 91749126 , 81911530241 , 81871549 , 81671900
6 · The paper itself

Abstract

The neuronal excitotoxicity that follows reoxygenation after a hypoxic period may contribute to epilepsy, Alzheimer's disease, Parkinson's disease and various disorders that are related to inadequate supplement of oxygen in neurons. Therefore, counteracting the deleterious effects of post-hypoxic stress is an interesting strategy to treat a large spectrum of neurodegenerative diseases. Here, we show that the expression of the key telomere protecting protein Trf2 decreases in the brain of mice submitted to a post-hypoxic stress. Moreover, downregulating the expression of Terf2 in hippocampal neural cells of unchallenged mice triggers an excitotoxicity-like phenotype including glutamate overexpression and behavioral alterations while overexpressing Terf2 in hippocampal neural cells of mice subjected to a post-hypoxic treatment prevents brain damages. Moreover, Terf2 overexpression in culture neurons counteracts the oxidative stress triggered by glutamate. Finally, we provide evidence that the effect of Terf2 downregulation on excitotoxicity involves Sirt3 repression leading to mitochondrial dysfunction. We propose that increasing the level of Terf2 expression is a potential strategy to reduce post-hypoxic stress damages.

Indexed as

NeuronsSirtuin 3Telomeric Repeat Binding Protein 2AnimalsBrainGlutamic AcidHippocampusHypoxiaMaleMiceMitochondriaOxidative StressTelomereGlutamic AcidSirt3 protein, mouseSirtuin 3Telomeric Repeat Binding Protein 2TRF2 protein, mouseExcitotoxicity-like phenotypeGlutamateNeuronsNeurotransmitterTerf2

Identifiers

PMID39128227
PMCPMC11369364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.